Global elimination of chronic hepatitis

DL Thomas - New England Journal of Medicine, 2019 - Mass Medical Soc
Global Elimination of Chronic Hepatitis | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review …

L Platt, S Minozzi, J Reed, P Vickerman, H Hagan… - …, 2018 - Wiley Online Library
Aims To estimate the effects of needle and syringe programmes (NSP) and opioid
substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C …

[PDF][PDF] Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America recommendations for testing …

MG Ghany, TR Morgan… - …, 2020 - Wiley Online Library
HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

L Platt, S Minozzi, J Reed, P Vickerman… - Cochrane Database …, 2017 - cochranelibrary.com
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C
transmission in people who inject drugs - Platt, L - 2017 | Cochrane Library Skip to Content …

Epidemiology and natural history of HCV infection

B Hajarizadeh, J Grebely, GJ Dore - Nature reviews Gastroenterology & …, 2013 - nature.com
Abstract Worldwide, an estimated 130–170 million people have HCV infection. HCV
prevalence is highest in Egypt at> 10% of the general population and China has the most …

[HTML][HTML] Approaches, progress, and challenges to hepatitis C vaccine development

JR Bailey, E Barnes, AL Cox - Gastroenterology, 2019 - Elsevier
Risk factors for hepatitis C virus (HCV) infection vary, and there were an estimated 1.75
million new cases worldwide in 2015. The World Health Organization aims for a 90 …

Randomized trial of a vaccine regimen to prevent chronic HCV infection

K Page, MT Melia, RT Veenhuis, M Winter… - … England Journal of …, 2021 - Mass Medical Soc
Background A safe and effective vaccine to prevent chronic hepatitis C virus (HCV) infection
is a critical component of efforts to eliminate the disease. Methods In this phase 1–2 …

[PDF][PDF] The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

J Grebely, K Page, R Sacks‐Davis… - …, 2014 - Wiley Online Library
Although 20%‐40% of persons with acute hepatitis C virus (HCV) infection demonstrate
spontaneous clearance, the time course and factors associated with clearance remain …

Initiation into prescription opioid misuse amongst young injection drug users

SE Lankenau, M Teti, K Silva, JJ Bloom… - International Journal of …, 2012 - Elsevier
BACKGROUND: Prescription opioids are the most frequently misused class of prescription
drugs amongst young adults. Initiation into prescription opioid misuse is an important public …

Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions

SP Kouyoumjian, H Chemaitelly, LJ Abu-Raddad - Scientific reports, 2018 - nature.com
Egypt is the most affected nation by hepatitis C virus (HCV) and needs a comprehensive
characterization of HCV epidemiology to inform the scale-up of treatment and prevention …